article_metadata: Shunya Yabuki Hiroyuki Hirai Chihiro Moriya Yoshiro Kusano Takeo Hasegawa
article_metadata: 10.3389/fendo.2024.1407192
article_metadata: Front Endocrinol (Lausanne)
article_metadata: 2024 May 22:15:1407192.
article_metadata: japanese glutamic acid decarboxylase antibody human leukocyte antigen haplotype immune checkpoint inhibitors type 1 diabetes mellitus
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38841300/
article_metadata: Diabetes Mellitus, Type 1 / chemically induced Diabetes Mellitus, Type 1 / drug therapy Diabetes Mellitus, Type 1 / genetics Glutamate Decarboxylase / immunology HLA-DQ beta-Chains / genetics HLA-DRB1 Chains / genetics Immune Checkpoint Inhibitors / adverse effects Immune Checkpoint Inhibitors / therapeutic use
article_metadata: Diabetes Mellitus, Type 1 / chemically induced Diabetes Mellitus, Type 1 / drug therapy Diabetes Mellitus, Type 1 / genetics Glutamate Decarboxylase / immunology HLA-DQ beta-Chains / genetics HLA-DRB1 Chains / genetics Immune Checkpoint Inhibitors / adverse effects Immune Checkpoint Inhibitors / therapeutic use Case Reports Aged Autoantibodies / blood Autoantibodies / immunology East Asian People Haplotypes Humans Ipilimumab / adverse effects Ipilimumab / therapeutic use Japan Lung Neoplasms / drug therapy Lung Neoplasms / genetics Male Nivolumab / adverse effects Nivolumab / therapeutic use Immune Checkpoint Inhibitors HLA-DRB1 Chains Glutamate Decarboxylase HLA-DQ beta-Chains HLA-DQB1 antigen Autoantibodies Nivolumab HLA-DRB1*04 antigen Ipilimumab
article_metadata: PMC11150800
article_metadata: 38841300
article_metadata: Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes
article_metadata: 2024